Yes go ahead and prove it. At least the company has enough sense...

Yes go ahead and prove it. At least the company has enough sense now not to use the word when it can not be proven. And since when did NOX leave it up to investors to join the dots. LOL

"DR. GOLDEN, Dr. Silvia Formenti, and their collaborators enrolled 41 patients with stable or progressing metastatic tumors (at least 3 distinct sites of measurable disease) on standard systemic treatments. The patients were maintained on their previous standard regimens and received subcutaneous administration of GM-CSF. They also received fractionated radiation to 1 of their measurable tumors, after which the nonirradiated tumors were evaluated by physical exam or computed tomography scans about 7 weeks into the treatment. The researchers defined an abscopal response as a reduction of 30% or more in any measurable nonirradiated tumor.
"http://www.ascopost.com/issues/november-25-2018/the-abscopal-effect-a-reemerging-field-of-interest/